← All trials
NCT07262723
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2025
- Primary completion
- Oct 30, 2026
- Completion date
- Dec 30, 2026
- First posted
- Dec 4, 2025
- Last posted
- Dec 4, 2025
- Enrollment
- 332
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Chittagong Medical CollegeLead sponsor
- Chittagong Medical CollegeSponsor investigator
- Pi Research Consultancy Center, BangladeshCollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.